These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1996570)

  • 21. Practical considerations of recombinant human erythropoietin therapy.
    Paganini EP; Latham D; Abdulhadi M
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):19-25. PubMed ID: 2667348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Morphologic and functional changes of left ventricle in dialyzed patients after treatment with recombinant human erythropoietin (r-HuEPO).
    Jeren-Struji'c B; Raos V; Jeren T; Horvatin-Godler S
    Angiology; 2000 Feb; 51(2):131-9. PubMed ID: 10701721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical efficacy of recombinant human erythropoietin in hemodialysis patients.
    Mohini R
    Semin Nephrol; 1989 Mar; 9(1 Suppl 1):16-21. PubMed ID: 2648516
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body fluid spaces and blood pressure in hemodialysis patients during amelioration of anemia with erythropoietin.
    Abraham PA; Opsahl JA; Keshaviah PR; Collins AJ; Whalen JJ; Asinger RW; McLain LA; Hanson G; Davis MG; Halstenson CE
    Am J Kidney Dis; 1990 Nov; 16(5):438-46. PubMed ID: 2239934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Peripheral hemodynamics, blood viscosity, and the renin-angiotensin system in hemodialysis patients under therapy with recombinant human erythropoietin.
    Steffen HM; Brunner R; Müller R; Degenhardt S; Pollok M; Lang R; Baldamus CA
    Contrib Nephrol; 1989; 76():292-8. PubMed ID: 2582783
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to hemodynamics.
    Tagawa H; Nagano M; Saito H; Umezu M; Yamakado M
    Clin Nephrol; 1991 Jan; 35(1):35-8. PubMed ID: 2007294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvements in quality of life following treatment with r-HuEPO in anemic hemodialysis patients.
    Delano BG
    Am J Kidney Dis; 1989 Aug; 14(2 Suppl 1):14-8. PubMed ID: 2757025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Blood rheology and hypertension in hemodialysis patients treated with erythropoietin.
    Schaefer RM; Leschke M; Strauer BE; Heidland A
    Am J Nephrol; 1988; 8(6):449-53. PubMed ID: 3218658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Influence of iron metabolism on the efficacy of r-HuEPO (recombinant human erythropoietin) treatment of anemia in children on hemodialysis].
    Pela I; Lavoratti GC; Materassi M; Burgio G; Bartolozzi G
    Pediatr Med Chir; 1991; 13(5):475-7. PubMed ID: 1788107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Diagnosis and therapy of renal anemia].
    Szegedi J
    Orv Hetil; 2008 Feb; 149(6):251-5. PubMed ID: 18238714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of recombinant human erythropoietin (rEPO) on angina pectoris in patients with chronic maintenance hemodialysis].
    Imamura Y; Hase H
    Nihon Jinzo Gakkai Shi; 1991 Apr; 33(4):403-8. PubMed ID: 1875559
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Working capacity is increased following recombinant human erythropoietin treatment.
    Mayer G; Thum J; Cada EM; Stummvoll HK; Graf H
    Kidney Int; 1988 Oct; 34(4):525-8. PubMed ID: 3199672
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular effects of recombinant human erythropoietin in predialysis patients.
    Portolés J; Torralbo A; Martin P; Rodrigo J; Herrero JA; Barrientos A
    Am J Kidney Dis; 1997 Apr; 29(4):541-8. PubMed ID: 9100042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of treatment with recombinant human erythropoietin on skeletal muscle function in patients with end-stage renal failure treated with regular hospital hemodialysis.
    Davenport A
    Am J Kidney Dis; 1993 Nov; 22(5):685-90. PubMed ID: 8238014
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effect of recombinant human erythropoietin (r-HuEPO) on left ventricular mass and left ventricular hemodynamics in hemodialysis patients.
    Minagawa T; Hirano T; Takada N; Ishiguro M; Ohtsuka H
    Nihon Jinzo Gakkai Shi; 1994 Aug; 36(8):934-41. PubMed ID: 7933670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term myocardial effects of correction of anemia with recombinant human erythropoietin in aged patients on hemodialysis.
    Martinez-Vea A; Bardají A; García C; Ridao C; Richart C; Oliver JA
    Am J Kidney Dis; 1992 Apr; 19(4):353-7. PubMed ID: 1532883
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autonomic dysfunction and the development of hypertension in patients treated with recombinant human erythropoietin (r-HuEPO).
    Roger SD; Baker LR; Raine AE
    Clin Nephrol; 1993 Feb; 39(2):103-10. PubMed ID: 8448912
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cerebrovascular incidents in 4 hemodialysis patients treated with erythropoietin].
    Zehnder C; Blumberg A
    Schweiz Med Wochenschr; 1988 Oct; 118(40):1423-6. PubMed ID: 3187475
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant human erythropoietin and its effects on macro- and microcirculation during normovolemia. A physiological study of hemodynamics, fluid status and skin microcirculation.
    Wirtz JJ; Leunissen KM; van Esser JW; Cheriex EC; Slaaf DW; Reneman RS; van Hooff JP
    Blood Purif; 1990; 8(5):285-94. PubMed ID: 2091688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Could CAPD modulate the hemodynamic changes induced by rHuEPO treatment?
    Fernández A; Vega N; Hortal L; Jimenez F; Laraudogoitía E; Macía M; Plaza C; Perdomo M; Palop L
    Adv Perit Dial; 1992; 8():435-9. PubMed ID: 1361842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.